Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis

Immune response to recombinantLeishmania infantumlipophosphoglycan 3 plus CpG oligodeoxynucleotides in BALB/c mice

(2017) L. Pirdel et al.   PARASITE IMMUNOLOGY

Analysis of iron superoxide dismutase-encoding DNA vaccine on the evolution of theLeishmania amazonensisexperimental infection

(2015) B. L. S. Campos et al.   PARASITE IMMUNOLOGY

Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice

(2015) Manuel Soto et al.   PLoS Neglected Tropical Diseases

Asymptomatic Leishmania Infection: A New Challenge for Leishmania Control

(2014) O. P. Singh et al.   CLINICAL INFECTIOUS DISEASES

Whole blood assay and visceral leishmaniasis: Challenges and promises

(2014) Om Prakash Singh et al.   IMMUNOBIOLOGY

Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis

(2014) Laura Ramirez et al.   Parasites & Vectors

Aggregation of Human Recombinant Monoclonal Antibodies Influences the Capacity of Dendritic Cells to Stimulate Adaptive T-Cell Responses In Vitro

(2014) Verena Rombach-Riegraf et al.   PLoS One

Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis

(2014) Bhavana Sethu Lakshmi et al.   VACCINE

BlockLogo: Visualization of peptide and sequence motif conservation

(2013) Lars Rønn Olsen et al.   JOURNAL OF IMMUNOLOGICAL METHODS

HLA Class I Alleles Are Associated with Peptide-Binding Repertoires of Different Size, Affinity, and Immunogenicity

(2013) S. Paul et al.   JOURNAL OF IMMUNOLOGY

Common variants in the HLA-DRB1–HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis

(2013) Michaela Fakiola et al.   NATURE GENETICS

Association of HLA-DRB1–restricted CD4+ T cell responses with HIV immune control

(2013) Srinika Ranasinghe et al.   NATURE MEDICINE

Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens

(2013) Xiaoming Jia et al.   PLoS One

Vaccination with Leishmania Hemoglobin Receptor-Encoding DNA Protects Against Visceral Leishmaniasis

(2013) R. Guha et al.   Science Translational Medicine

Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis

(2013) Laura Ramírez et al.   VACCINE

Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis

(2012) Om Prakash Singh et al.   PLoS Neglected Tropical Diseases

Immunogenicity of Leishmania donovani iron superoxide dismutase B1 and peroxidoxin 4 in BALB/c mice: The contribution of Toll-like receptor agonists as adjuvant

(2011) Nada S. Daifalla et al.   EXPERIMENTAL PARASITOLOGY

HIV-Specific CD4 T Cell Responses to Different Viral Proteins Have Discordant Associations with Viral Load and Clinical Outcome

(2011) S. Ranasinghe et al.   JOURNAL OF VIROLOGY

Evaluation of Ex Vivo Human Immune Response against Candidate Antigens for a Visceral Leishmaniasis Vaccine

(2010) Rajiv Kumar et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Peptide binding predictions for HLA DR, DP and DQ molecules

(2010) Peng Wang et al.   BMC BIOINFORMATICS

MHC Class II Binding Prediction—A Little Help from a Friend

(2010) Ivan Dimitrov et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction

(2009) Morten Nielsen et al.   BMC BIOINFORMATICS

HLA and Infectious Diseases

(2009) J. M. Blackwell et al.   CLINICAL MICROBIOLOGY REVIEWS

KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major

(2009) Suniti Bhaumik et al.   VACCINE

Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals

(2008) Naghmeh Khoshgoo et al.   VACCINE